iMetabolic Biopharma Corporation is engaged in drug discovery using a tech-powered approach to improve traditional biotechnology methods. It focuses on making drugs more effective and affordable.

iMetabolic Biopharma Corporation

iMetabolic Biopharma Corporation | 380 followers on LinkedIn. Improving Health Through Innovation | iMetabolic Biopharma Corporation (iMBP) is an exciting early stage platform biopharma company that is developing First In Class therapeutics for the treatment of a number of diseases with high unmet medical need. Through the application of its proprietary iPlatform technology, iMBP has established itself as a Leader in TechBio, a nouveau field of drug discovery and development driven by technology innovation. Having already established a pipeline of five early stage therapeutic assets, with additional molecules already in design phase, iMBP is at the precipice in its next leg of evolution.

Nathan Hyland

Business Development | Corporate Development | Product Development | Vendor Management

Ryan Haverstock

PhD Biochemist | Protein Engineering and Structural Biology Expert | Fluorescence Assay Developer | Passionate About Biotechnology Innovation

Patrick Kelly, PhD

Marty Emanuele

We were featured in VentureBeat . Great job iMBP team.

Check out our CEO as he shares the stage some Health and Wellness industry superstars. We are at a critical inflection point and Urban A. Kiernan, Ph.D. lays it out there!

We are thrilled to announce that iMBP has received its second NIH grant, a significant milestone in our journey. Recently, our Founder and CEO shared insights on the DNA of Things Podcast, discussing the evolution of iMBP and its impact on the scientific community. Listen to the full episode to learn more. #iMBPSuccess #NIHGrant #ResearchInnovation #Podcast #LifeScience

iMetabolic Biopharma (iMBP) just got featured on Venture Capital Post for being a leader in the TechBio industry! The article outlines exactly what differentiates us as TechBio from the traditional biopharma players in dealing with: - Excessive drug discovery cost, - Less than desirable therapeutic performance and - Extreme timelines in getting drugs to market. We are so excited about the direction our company is growing and know that there is so much more to come. Thank you to every iMBP community member who have made it possible for us to get to this point. We are excited to be on this journey with you! 🙏 🙏 If you want to read the full article, see the post below 👇 Thank you VCPost Inc. for picking up the iMBP story

This is our Founder and CEO, Urban A. Kiernan, Ph.D. . Register today for this mind blowing event🤯…IGNITE by Coach360 🔥🔥🔥. Nexgen MD 360 Bob Thomas Eloiza Tecson Nathan Hyland Kathleen Ferguson

As we approach the fiscal year-end, it's crucial to stay updated on new grant funding opportunities. Also, the recent Decoding Health Podcast episode featuring Dr. Malú Gamez Tansey sheds light on Alzheimer’s Disease and gut health's impact on disease development. Stay informed. #FiscalYearEnd #GrantFunding #Healthcare #Research #AlzheimersDisease

This is a great opportunity for Urban A. Kiernan, Ph.D. to showcase his knowledge base and engage with experts to break down the black box of science. Have a watch: https://lnkd.in/grh6zeaW

Small business supporting small business is how progress gets done. Congratulations to Dr. Micah Olson and Valley Healthspan on the launch!

Exciting news! This summer, the Decoding Health Podcast by Dr. Urban A. Kiernan will be launching. Stay informed on health and science topics with weekly episodes and shorts covering GLP-1 RA, Alzheimer’s Disease, AI in drug development, and more. Join the iMBP community and learn from leading experts in the field. Link in bio. Don't miss this opportunity! #DecodingHealth #HealthPodcast #HealthScience #iMBPCommunity #SciencePodcast

Brilliance in thought right here. Don’t take market share…create the market. To me and iMetabolic Biopharma Corporation , that is the whole point of innovation. #innovation #imbp #therapeutics #biotech #techbio

IMBI

COM:IMBIOPHARMA

iMetabolic Biopharma Corporation